New Tools for Precision Targeting of Origin-Specific Vascular Smooth Muscle Cells Using Intersectional Genetics

Mark W. Majesky

doi:10.1161/circulationaha.125.073364

New Tools for Precision Targeting of Origin-Specific Vascular Smooth Muscle Cells Using Intersectional Genetics

M Mark W. Majesky (Center for Developmental Biology & Regenerative Medicine, Seattle Children’s Research Institute, Seattle, WA. Heart Center, Division of Cardiology, Seattle Children’s Hospital, Seattle, WA. Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, 98105.)

View Original

APA MLA Chicago BibTeX RIS

Article Details

Journal Circulation

Volume / Issue Vol. 151, Issue 17

Published April 29, 2025

Pages 1268-1271

DOI 10.1161/circulationaha.125.073364

ISSN 0009-7322

Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (1)

M

Mark W. Majesky

Center for Developmental Biology & Regenerative Medicine, Seattle Children’s Research Institute, Seattle, WA. Heart Center, Division of Cardiology, Seattle Children’s Hospital, Seattle, WA. Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, 98105.

New Tools for Precision Targeting of Origin-Specific Vascular Smooth Muscle Cells Using Intersectional Genetics

Article Details

Journal Info

Authors (1)

Related Articles from this Journal

Occupational Radiation Safety in Electrophysiology During Pregnancy: Evaluating Uterine Radiation Doses During Catheter Ablations and Device Implantations

Response by Rogers et al to Letter Regarding, “Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation”

Clinical Cardiology at the Crossroads: Perspectives on the Next Era at <i>Circulation</i>

ABHD11-Mediated mtDNA Transcription Restored Mitochondrial Function to Attenuate Cardiomyocyte Ferroptosis After Myocardial Infarction

Letter by Li et al Regarding Article, “Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation”